bullish
BUY Vinda (3331 HK): Thesis Confirmed
440 Views24 Aug 2018 13:19
In our June'18 BUY note on Vinda we highlight the upside of management's new stock-price-driven incentive scheme and Vinda's ability...
SUMMARY
(Sign Up to Access)Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
- Unlock all research summaries
- Follow top, independent analysts
- Receive personalised alerts and emails
- Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 62-minute read)
Discussions
(Paid Plans Only)
Bucephalus Research Partnership
Exposing Creative Accounting
- Prefer Vinda Even If Hengan Surprises Near-Term; CG Issues Need More Light14 Jan 2020
- BUY Vinda (3331 HK): Thesis Confirmed24 Aug 2018
- SELL Hengan (1044 HK): Thesis Confirmed24 Aug 2018
- Buy Vinda (3331 HK): New Incentives, Leverage & Margins - Target HK$25.2 (Up 80%+)13 Aug 2018
- Moving up the value chain, catching up with Hengan, opportunity to accumulate27 May 2015
x